[go: up one dir, main page]

FI951468L - Lipopeptidijohdannaiset, menetelmä niiden valmistamiseksi ja niiden käyttö - Google Patents

Lipopeptidijohdannaiset, menetelmä niiden valmistamiseksi ja niiden käyttö Download PDF

Info

Publication number
FI951468L
FI951468L FI951468A FI951468A FI951468L FI 951468 L FI951468 L FI 951468L FI 951468 A FI951468 A FI 951468A FI 951468 A FI951468 A FI 951468A FI 951468 L FI951468 L FI 951468L
Authority
FI
Finland
Prior art keywords
preparation
lipopeptide derivatives
lipopeptide
derivatives
Prior art date
Application number
FI951468A
Other languages
English (en)
Swedish (sv)
Other versions
FI951468A0 (fi
FI951468A7 (fi
Inventor
Rudolf Lattrell
Theodor Wollmann
Holger Wallmeier
Peter Hammann
Dieter Isert
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of FI951468A0 publication Critical patent/FI951468A0/fi
Publication of FI951468A7 publication Critical patent/FI951468A7/fi
Publication of FI951468L publication Critical patent/FI951468L/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FI951468A 1994-03-30 1995-03-28 Lipopeptidijohdannaiset, menetelmä niiden valmistamiseksi ja niiden käyttö FI951468L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4411025A DE4411025A1 (de) 1994-03-30 1994-03-30 Lipopeptid-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung

Publications (3)

Publication Number Publication Date
FI951468A0 FI951468A0 (fi) 1995-03-28
FI951468A7 FI951468A7 (fi) 1995-10-01
FI951468L true FI951468L (fi) 1995-10-01

Family

ID=6514230

Family Applications (1)

Application Number Title Priority Date Filing Date
FI951468A FI951468L (fi) 1994-03-30 1995-03-28 Lipopeptidijohdannaiset, menetelmä niiden valmistamiseksi ja niiden käyttö

Country Status (24)

Country Link
US (1) US5629288A (fi)
EP (1) EP0688789B1 (fi)
JP (1) JP3653119B2 (fi)
KR (1) KR100360129B1 (fi)
CN (1) CN1111640A (fi)
AT (1) ATE219499T1 (fi)
AU (1) AU696566B2 (fi)
CA (1) CA2145826C (fi)
CZ (1) CZ287158B6 (fi)
DE (2) DE4411025A1 (fi)
DK (1) DK0688789T3 (fi)
ES (1) ES2178657T3 (fi)
FI (1) FI951468L (fi)
HU (1) HU218286B (fi)
IL (1) IL113160A (fi)
MA (1) MA23490A1 (fi)
NO (1) NO951198L (fi)
NZ (1) NZ270828A (fi)
OA (1) OA10142A (fi)
PL (1) PL180274B1 (fi)
PT (1) PT688789E (fi)
RU (1) RU2141970C1 (fi)
TW (1) TW336939B (fi)
ZA (1) ZA952555B (fi)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5965524A (en) * 1989-07-07 1999-10-12 Peptide Technologies Corporation Analogs of viscosin and uses thereof
TW455591B (en) * 1993-06-08 2001-09-21 Hoechst Ag Lipopeptides from actinoplanes sp. with pharmacological action, process for their production and the use thereof
DE4411025A1 (de) * 1994-03-30 1995-10-05 Hoechst Ag Lipopeptid-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung
US6406880B1 (en) * 1997-05-02 2002-06-18 Integrated Research Technology, Llc Betaines as adjuvants to susceptibility testing and antimicrobial therapy
US7067500B2 (en) * 1997-05-02 2006-06-27 Integrated Research Technology, Llc Betaines as adjuvants to susceptibility testing and antimicrobial therapy
AU9464398A (en) * 1997-10-21 1999-05-10 Sankyo Company Limited Novel antifungal compounds
DE19807972A1 (de) * 1998-02-25 1999-08-26 Hoechst Marion Roussel De Gmbh Lipopeptidantibiotika-Calciumsalze, Verfahren zu ihrer Herstellung und Verwendung
AU3837600A (en) * 1999-04-16 2000-11-02 Sankyo Company Limited Novel antifungal compounds
US7408025B2 (en) 1999-12-15 2008-08-05 Cubist Pharmaceuticals, Inc. Lipopeptides as antibacterial agents
EP2298790A1 (en) 1999-12-15 2011-03-23 Cubist Pharmaceuticals, Inc. Daptomycin analogs as antibacterial agents
JP2003517003A (ja) * 1999-12-15 2003-05-20 キュービスト ファーマシューティカルズ， インコーポレイテッド ダプトマイシンアナログおよび抗菌剤としてのそれらの使用
US6696412B1 (en) 2000-01-20 2004-02-24 Cubist Pharmaceuticals, Inc. High purity lipopeptides, Lipopeptide micelles and processes for preparing same
US6511962B1 (en) * 2000-07-17 2003-01-28 Micrologix Biotech Inc. Derivatives of laspartomycin and preparation and use thereof
AU7893301A (en) * 2000-07-17 2002-01-30 Intrabiotics Pharmaceuticals Antimicrobial sulfonamide derivatives of lipopeptide antibiotics
US6750199B2 (en) 2000-07-17 2004-06-15 Micrologix Biotech Inc. Antimicrobial sulfonamide derivatives of lipopeptide antibiotics
US6737403B2 (en) 2000-07-17 2004-05-18 Micrologix Biotech Inc. Derivatives of laspartomycin and preparation and use thereof
US20060014674A1 (en) 2000-12-18 2006-01-19 Dennis Keith Methods for preparing purified lipopeptides
IL156394A0 (en) 2000-12-18 2004-01-04 Cubist Pharm Inc Methods for preparing purified lipopeptides
CA2456761A1 (en) * 2001-08-06 2003-02-20 Cubist Pharmaceuticals, Inc. Novel depsipeptides and process for preparing same
WO2003057724A1 (en) 2002-01-03 2003-07-17 Micrologix Biotech Inc. Dab9 DERIVATIVES OF LIPOPEPTIDE ANTIBIOTICS AND METHODS OF MAKING AND USING THE SAME
EP1656390A2 (en) 2003-07-17 2006-05-17 Migenix Inc. Compositions of lipopeptide antibiotic derivatives and methods of use thereof
US8420602B2 (en) * 2004-09-14 2013-04-16 Landon C. G. Miller Endocannabinoid conjugate and a pharmaceutical composition for treatment of neuronal disorders
US7795207B2 (en) 2005-11-21 2010-09-14 Harald Labischinski Lipopeptide compositions
DE102005056194A1 (de) * 2005-11-21 2007-07-12 Combinature Biopharm Ag Neue Lipopeptid Zusammensetzungen
US20080057047A1 (en) * 2005-11-29 2008-03-06 Benedikt Sas Use of bacillus amyloliquefaciens PB6 for the prophylaxis or treatment of gastrointestinal and immuno-related diseases
TWI409077B (zh) * 2006-04-18 2013-09-21 Piramal Life Sciences Ltd 新穎抗菌化合物
US7888940B2 (en) * 2007-02-19 2011-02-15 Schlumberger Technology Corporation Induction resistivity cover
GB0821540D0 (en) 2008-11-25 2008-12-31 Merlion Pharmaceuticals Pte Ltd Lipopeptide compounds and their use
JP5670914B2 (ja) * 2008-12-22 2015-02-18 キュービスト ファーマシューティカルズ， インコーポレイテッド グラム陽性菌感染症を処置するための新規抗菌剤
SI2504353T2 (sl) 2009-11-23 2023-11-30 Cubist Pharmaceuticals Llc Lipopeptidni sestavki in s tem povezane metode
CN103554230B (zh) * 2013-09-18 2015-07-22 福建省微生物研究所 一种安福霉素类化合物及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8005121A (nl) * 1979-09-20 1981-03-24 Erba Farmitalia Biologisch actieve peptiden.
CA1337758C (en) * 1988-04-11 1995-12-19 Eli Lilly And Company Peptide antibiotics
US5049546A (en) * 1990-03-19 1991-09-17 Merck & Co., Inc. Antibiotic agents
US5306708A (en) * 1990-12-19 1994-04-26 Merck & Co., Inc. Antibiotic agent
TW455591B (en) * 1993-06-08 2001-09-21 Hoechst Ag Lipopeptides from actinoplanes sp. with pharmacological action, process for their production and the use thereof
DE4411025A1 (de) * 1994-03-30 1995-10-05 Hoechst Ag Lipopeptid-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung

Also Published As

Publication number Publication date
RU2141970C1 (ru) 1999-11-27
PT688789E (pt) 2002-11-29
TW336939B (en) 1998-07-21
CA2145826C (en) 2008-01-08
CA2145826A1 (en) 1995-10-01
EP0688789A1 (de) 1995-12-27
RU95106362A (ru) 1996-12-27
MA23490A1 (fr) 1995-10-01
DE59510246D1 (de) 2002-07-25
FI951468A0 (fi) 1995-03-28
PL307914A1 (en) 1995-10-02
AU1611095A (en) 1995-10-12
DE4411025A1 (de) 1995-10-05
IL113160A0 (en) 1995-06-29
HUT71584A (en) 1995-12-28
OA10142A (fr) 1996-12-18
JPH07278186A (ja) 1995-10-24
DK0688789T3 (da) 2002-10-14
CN1111640A (zh) 1995-11-15
JP3653119B2 (ja) 2005-05-25
US5629288A (en) 1997-05-13
NO951198D0 (no) 1995-03-29
AU696566B2 (en) 1998-09-10
FI951468A7 (fi) 1995-10-01
HK1012017A1 (en) 1999-07-23
CZ77995A3 (en) 1995-10-18
PL180274B1 (pl) 2001-01-31
NZ270828A (en) 1996-10-28
ATE219499T1 (de) 2002-07-15
EP0688789B1 (de) 2002-06-19
IL113160A (en) 1999-04-11
KR950032636A (ko) 1995-12-22
KR100360129B1 (ko) 2003-03-26
ES2178657T3 (es) 2003-01-01
ZA952555B (en) 1995-12-21
HU218286B (en) 2000-07-28
NO951198L (no) 1995-10-02
CZ287158B6 (en) 2000-10-11

Similar Documents

Publication Publication Date Title
FI951468A7 (fi) Lipopeptidijohdannaiset, menetelmä niiden valmistamiseksi ja niiden käyttö
FI962927A7 (fi) Tetrasykliinijohdannaisia, valmistusmenetelmä ja käyttö
FI955235A7 (fi) Oksatsolidiinionijohdannaiset, niiden valmistus ja käyttö
EE9500064A (et) Asendatud 1H-imidasoolid, nende valmistamismeetodid ja farmatseutilised kompositsioonid
FI962917A7 (fi) Mikrokapselit, menetelmä niiden valmistamiseksi, ja niiden käyttö
EE03568B1 (et) Bensimidasooli derivaadid, nende valmistamismeetod ja kasutamine
EE9900147A (et) Oksadiasoolid, nende saamismeetodid ja kasutamine ravimitena
FI955913A0 (fi) Uudet erytromysiinijohdannaiset, menetelmät niiden valmistamiseksi ja niiden käyttö lääkkeinä
FI941137A7 (fi) 2-debentsoyyli-2-asyylitaksolijohdannaisia ja menetelmiä niiden valmistamiseksi
EE03482B1 (et) Kinasoliiniderivaadid, nende valmistamismeetod ja kasutamine
FI953898A7 (fi) Glysiiniamidijohdannaisia, menetelmiä niiden valmistamiseksi ja niitä sisältäviä lääkeaineita
FI931499A7 (fi) Syklopeptidit, menetelmä niiden valmistamiseksi ja niiden käyttö lääke aineina
FI973195L (fi) Hairuston uutteet, menetelmä niiden valmistamiseksi ja niiden käyttö
EE9800302A (et) Arüülglütsiinamiidi derivaadid, nende valmistamismeetod ja kasutamine ning farmatseutiline preparaat
EE9900112A (et) 2-tsüanoiminoimidasooli derivaadid, nende valmistamismeetod, kasutamine ja farmatseutilised kompositsioonid
EE9800145A (et) Fenüülamidiini derivaadid, meetodid nende valmistamiseks ja nende kasutamine arstimitena
FI970997L (fi) Bentsosykloalkeeniyhdisteet, niiden valmistus ja käyttö
FI951631L (fi) Substituoituja kynureniinejä, menetelmä niiden valmistamiseksi ja niiden käyttö lääkkeinä
FI972988L (fi) Menetelmiä ja farmaseuttisia koostumuksia, joissa käytetään desmetyyliselegiliiniä
FI923755A7 (fi) Disulfideja, menetelmiä niiden valmistamiseksi ja niiden käyttö
FI941914A0 (fi) 2-amino-4-kinoliinidihydropyridiinejä, menetelmiä niiden valmistamiseksi ja niiden käyttö
FI953956A7 (fi) 2,3-rengaskondensoidut 1,4-dihydropyridiinit, menetelmät niiden valmistamiseksi ja niiden käyttö lääkkeinä
EE9800333A (et) Uued furaandiarüülmetülideeni derivaadid, nende valmistamise meetod ja kasutamine teraapias
FI973434L (fi) Aminotetralonijohdannaisia ja menetelmä niiden valmistamiseksi
FI970750L (fi) Indoli-2,3-dioni-3-oksimijohdannaisia, niiden valmistus ja käyttö

Legal Events

Date Code Title Description
MA Patent expired